[1]张丽娜,张胜英.低分子肝素钙预防高危产妇剖宫产术后下肢静脉血栓的临床观察[J].医学信息,2019,32(21):95-97.[doi:10.3969/j.issn.1006-1959.2019.21.029]
　ZHANG Li-na,ZHANG Sheng-ying.Clinical Observation of Low Molecular Weight Heparin Calcium in Prevention of Lower Extremity Venous Thrombosis after High-Risk Maternal Cesarean Section[J].Journal of Medical Information,2019,32(21):95-97.[doi:10.3969/j.issn.1006-1959.2019.21.029]
点击复制

低分子肝素钙预防高危产妇剖宫产术后下肢静脉血栓的临床观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年21期
页码:
95-97
栏目:
临床研究
出版日期:
2019-11-01

文章信息/Info

Title:
Clinical Observation of Low Molecular Weight Heparin Calcium in Prevention of Lower Extremity Venous Thrombosis after High-Risk Maternal Cesarean Section
文章编号:
1006-1959（2019）21-0095-03
作者:
张丽娜; 张胜英
（江苏省苏州市吴中人民医院产科，江苏 苏州 215000）
Author(s):
ZHANG Li-na; ZHANG Sheng-ying
(Department of Obstetrics,Wuzhong People's Hospital,Suzhou 215000,Jiangsu,China)
关键词:
下肢静脉血栓; 低分子肝素钙; 剖宫产术
Keywords:
Lower extremity venous thrombosis; Low molecular weight heparin calcium; Cesarean section
分类号:
R791.8
DOI:
10.3969/j.issn.1006-1959.2019.21.029
文献标志码:
A
摘要:
目的 观察低分子肝素钙在预防高危产妇剖宫产术后下肢静脉血栓（DVT）的临床疗效。方法 选择我院2016年1月~2018年12月具有下肢深静脉血栓形成高危因素的剖宫产分娩产妇120例，随机分为对照组和治疗组，各60例。对照组给予机械措施干预，治疗组在机械措施基础上给予低分子肝素钙干预。比较两组产妇术后凝血功能指标（PT、APTT、FIB、D-二聚体）PLT及产后出血量、DVT发生率。结果 治疗组术后FIB、D-二聚体值低于对照组，APTT、PT均高于对照组，差异具有统计学意义（P＜0.05）；治疗组DVT发生率低于对照组，差异有统计学意义（P＜0.05）；两组PLT、产后出血量比较，差异无统计学意义（P＞0.05）。结论 低分子肝素钙可有效改善高危产妇术后血液高凝状态，预防高危产妇剖宫产术后下肢深静脉血栓形成，降低DVT发生率，且并不增加产后出血风险，治疗安全、有效，不影响母乳喂养，适于在临床工作借鉴应用。
Abstract:
Objective To observe the clinical efficacy of low molecular weight heparin calcium in the prevention of lower extremity venous thrombosis (DVT) after high-risk maternal cesarean section. Methods 120 patients with cesarean delivery who had high risk factors for deep venous thrombosis of lower extremity from January 2016 to December 2018 were randomly divided into control group and treatment group, 60 cases each. The control group was given mechanical intervention, and the treatment group was given low molecular weight heparin calcium intervention based on mechanical measures. The postoperative coagulation function indexes (PT, APTT, FIB, D-dimer) PLT and the incidence of postpartum hemorrhage and DVT were compared between the two groups.Results The FIB and D-dimer values in the treatment group were lower than those in the control group, and the APTT and PT were higher than the control group,the difference was statistically significant (P<0.05). The incidence of DVT in the treatment group was lower than that in the control group,the difference was statistically significant (P<0.05). There was no significant difference in PLT and postpartum hemorrhage between the two groups (P>0.05).Conclusion Low molecular weight heparin calcium can effectively improve the postoperative hypercoagulability of high-risk maternal women, prevent deep venous thrombosis after high-risk maternal cesarean section, reduce the incidence of DVT, and does not increase the risk of postpartum hemorrhage. The treatment is safe and effective. Affect breastfeeding, suitable for reference in clinical work.

参考文献/References:

[1]Stone J,Hangge P,Albadawi H,et al.Deep vein thrombosis:pathogenesis,diagnosis,and medical management[J].Cardiovasc Diagn Ther,2017,7(Suppl 3):S276-S284. [2]Weiss N,Bernstein PS.Risk factor scoring for predicting venous thromboembolism in obstetric patients[J].Am J Obstet Gynecol,2000,182(5):1073-1075. [3]Akinshina S,Makatsariya A,Bitsadze V,et al.Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis[J].J Perinat Med,2018,46(8):893-899. [4]赵纪春,吴洲鹏.静脉血栓栓塞症治疗进展[J].中国实用外科杂志,2015,35(12):1348-1351. [5]Wen T,Wright JD,Goffman D,et al.Postpartum venous thromboembolism readmissions in the United States[J].Am J Obstet Gynecol,2018,219(4):401.e1-401.e14. [6]Gharaibeh L,Sartawi H,Ayyad D,et al.Evaluation of venous thromboembolism prophylaxis in a major hospital in a developing country[J].Int J Clin Pharm,2017,39(4):881-887. [7]ACOG Practice Bulletin No.196 Summary:Thromboembolism in Pregnancy[J].Obstet Gynecol,2018,132(1):243-248. [8]Palmerola KL,D'Alton ME,Brock CO,et al.A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines[J].BJOG,2016,123(13):2157-2162. [9]Bartholomew JR.Heparin-induced thrombocytopenia:2008 update[J].Curr Treat Options Cardiovasc Med,2008,10(2):117-127. [10]Greer IA,Neison-Piercy C.Low-molecular-weight heparins for thromboptrop-hylaxis and treatment of venous thromboembolism in pregnancy:a systematic review of safety and efficacy [J].Blood,2005,106(2):401-407. [11]Kupferminc M,Rimon E,Many A,et al.Low molecular weight heparin versus no treatment in women with previous severs previous severe pregnancy complications and placental findings without thrombophilia[J].Blood Coagul Fibrinolysis,2011,22(2):123-126. [12]刘章,姬胜利,王凤山,等.低分子肝素的药理作用和临床应用研究进展[J]药物生物技术,2014,21(6):573-578. [13]Koltsova EM,Balandina AN,Grischuk KI,et al.The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery[J].J Perinat Med,2018,46(3):251-260.

相似文献/References:

[1]邹万芹,孙立军.地屈孕酮联合低分子肝素钙治疗先兆流产患者的效果[J].医学信息,2019,32(14):151.[doi:10.3969/j.issn.1006-1959.2019.14.050]
　ZOU Wan-qin,SUN Li-jun.Effect of Dydrogesterone Combined with Low Molecular Weight Heparin Calcium in Patients with Threatened Abortion[J].Journal of Medical Information,2019,32(21):151.[doi:10.3969/j.issn.1006-1959.2019.14.050]
[2]李大千,蒋 云,梅燕萍.抗凝血酶Ⅲ、D-二聚体与纤维蛋白原在 下肢静脉血栓形成中的临床应用[J].医学信息,2019,32(17):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
　LI Da-qian,JIANG Yun,MEI Yan-ping.Clinical Application of Antithrombin III,D-dimer and Fibrinogen in Venous Thrombosis of Lower Extremity[J].Journal of Medical Information,2019,32(21):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
[3]贾科锋,魏召劝,郭亚堂,等.阿哌沙班与低分子肝素钠在膝关节置换术后抗凝治疗的对比[J].医学信息,2022,35(15):55.[doi:10.3969/j.issn.1006-1959.2022.15.011]
　JIA Ke-feng,WEI Zhao-quan,GUO Ya-tang,et al.Comparison of Anticoagulant Therapy Between Apixaban and Low Molecular Heparin Sodium After Knee Arthroplasty[J].Journal of Medical Information,2022,35(21):55.[doi:10.3969/j.issn.1006-1959.2022.15.011]
[4]蔡庆宇,刘海洲.利伐沙班和低分子肝素钙预防中重度脑出血术后下肢深静脉血栓形成的效果比较[J].医学信息,2021,34(08):150.[doi:10.3969/j.issn.1006-1959.2021.08.040]
　CAI Qing-yu,LIU Hai-zhou.Comparison of the Effects of Rivaroxaban and Low-molecular-weight Heparin Calcium in Preventing Deep Vein Thrombosis of Lower Extremities After Moderate to Severe Intracerebral Hemorrhage[J].Journal of Medical Information,2021,34(21):150.[doi:10.3969/j.issn.1006-1959.2021.08.040]

更新日期/Last Update: 2019-11-01